XTRA:FREHealthcare
Fresenius SE KGaA (XTRA:FRE) Margin Rebound Tests Long Term Earnings Skepticism
Fresenius SE KGaA (XTRA:FRE) has just wrapped up FY 2025 with fourth quarter revenue of €5.96b and basic EPS of €0.70, capping off a trailing twelve month run where revenue reached €22.45b and EPS came in at €1.94 by the end of Q3 2025, alongside earnings growth of 25.2% over the last year. Over recent periods the company has seen revenue move from €21.48b in the twelve months to Q3 2024 to €22.45b in the twelve months to Q3 2025, while EPS over the same stretch went from €1.55 to €1.94. This...